A novel intranasal Protollin™-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice

被引:41
作者
Chabot, S
Brewer, A
Lowell, G
Plante, M
Cyr, S
Burt, DS
Ward, BJ
机构
[1] McGill Univ, Montreal Gen Hosp, Res Inst, Dept Trop Med, Montreal, PQ H3G 1A4, Canada
[2] ID Biomed Corp Quebec, St Laurent, PQ, Canada
基金
加拿大健康研究院;
关键词
vaccine; measles; adjuvants; mucosal vaccination; neutralization; antibody; IgA; interferon-gamma;
D O I
10.1016/j.vaccine.2004.09.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Protollin-MV is a vaccine produced by mixing split measles virus (MV) antigen with the novel adjuvant Protollin(TM) (Neisseria meningitidis outer membrane proteins non-covalently complexed with Shigella flextneri 2a lipopolysaccharide). Intranasal immunization of mice with two or three doses of Protollin-MV induces both serum IgG and mucosal IgA with strong neutralizing activity. There is a dose-dependent shift towards lower IgG(1):IgG(2a), ratios and MV-specific IFNgamma production in splenocytes. Intranasal Protollin-MV can therefore induce systemic and mucosal neutralizing antibody responses as well as elicit a balanced T-H 1/T(H)2-type response. (C) 2004 Published by Elsevier Ltd.
引用
收藏
页码:1374 / 1383
页数:10
相关论文
共 45 条
[31]   Altered synthesis of interleukin-12 and type 1 and type 2 cytokines in rhesus macaques during measles and atypical measles [J].
Polack, FP ;
Hoffman, SJ ;
Moss, WJ ;
Griffin, DE .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (01) :13-19
[32]   Experimental vaccines against measles in a world of changing epidemiology [J].
Pütz, MM ;
Bouche, FB ;
de Swart, RL ;
Muller, CP .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2003, 33 (5-6) :525-545
[33]   Measles virus 1998-2002: Progress and controversy [J].
Rall, GF .
ANNUAL REVIEW OF MICROBIOLOGY, 2003, 57 :343-367
[34]  
RIMA BK, 1995, CURR TOP MICROBIOL, V191, P65
[35]   ADDITIONAL EVIDENCE THAT CELL-ASSOCIATED IMMUNE SYSTEM IS PRIMARY HOST DEFENSE AGAINST MEASLES (RUBEOLA) [J].
RUCKDESCHEL, JC ;
GRAZIANO, KD ;
MARDINEY, MR .
CELLULAR IMMUNOLOGY, 1975, 17 (01) :11-18
[36]   Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV [J].
Schmidt, U ;
Beyer, J ;
Polster, U ;
Gershwin, LJ ;
Buchholz, UJ .
JOURNAL OF VIROLOGY, 2002, 76 (23) :12355-12359
[37]   Cytokine responses during mucosal infections: role in disease pathogenesis and host defence [J].
Svanborg, C ;
Godaly, G ;
Hedlund, M .
CURRENT OPINION IN MICROBIOLOGY, 1999, 2 (01) :99-105
[38]   Toll-like receptors [J].
Takeda, K ;
Kaisho, T ;
Akira, S .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :335-376
[39]   Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies [J].
vanBinnendijk, RS ;
Poelen, MCM ;
vanAmerongen, G ;
deVries, P ;
Osterhaus, ADME .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (03) :524-532
[40]   PROTECTION AGAINST LETHAL MEASLES-VIRUS INFECTION IN MICE BY IMMUNE-STIMULATING COMPLEXES CONTAINING THE HEMAGGLUTININ OR FUSION PROTEIN [J].
VARSANYI, TM ;
MOREIN, B ;
LOVE, A ;
NORRBY, E .
JOURNAL OF VIROLOGY, 1987, 61 (12) :3896-3901